companyprofile
Actions
Mouwasat Medical Services Co.
- Main Market
- Health Care Equipment & Svc
- Shares Type
- Common Shares
Stats Overview
-
Prev. Close 68.55
-
Open 68.60
-
High 68.85
-
Low 67.40
-
YTD% Change1.13
-
No. of Trades 2,561
-
Avg. Trade size* 163
-
Volume Traded 417,412
-
Value Traded (^) 28,401,886.60
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 01/09/2025 | 04/12/2025 | 15/12/2025 | Account Transfer | ^1.00 |
| 23/12/2024 | 05/05/2025 | 15/05/2025 | Account Transfer | ^2.00 |
| 25/12/2023 | 27/05/2024 | 06/06/2024 | Account Transfer | ^1.75 |
| 22/12/2022 | 07/05/2023 | 17/05/2023 | Account Transfer | ^3.00 |
| 17/01/2022 | 09/05/2022 | 19/05/2022 | Account Transfer | ^2.75 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2024-12-31 | 2023-12-31 | ||
|---|---|---|---|---|
| Total Assets |
5,402,800
|
4,964,547
|
- | - |
| Total Liabilities |
1,689,230
|
1,537,700
|
- | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
3,568,338
|
3,277,056
|
- | - |
| Total Liabilities and Shareholders Equity |
5,402,800
|
4,964,547
|
- | - |
| Statement of Income | 2024-12-31 | 2023-12-31 | ||
| Total Revenue (Sales/Operating) |
2,879,372
|
2,705,508
|
- | - |
| Net Profit (Loss) before Zakat and Tax |
681,945
|
696,387
|
- | - |
| Zakat and Income Tax |
-36,186
|
-38,699
|
- | - |
| Net Profit (Loss) Attributable to Shareholders of the Issuer |
645,759
|
657,688
|
- | - |
| Total Comprehensive Income Attributable to Shareholders of the Issuer |
641,282
|
654,210
|
- | - |
| Profit (Loss) per Share |
3.23
|
3.29
|
- | - |
| Cash Flows | 2024-12-31 | 2023-12-31 | ||
| Net Cash From Operating Activities |
1,256,428
|
813,783
|
- | - |
| Net Cash From Investing Activities |
-467,500
|
-474,702
|
- | - |
| Net Cash From Financing Activities |
-411,403
|
-433,908
|
- | - |
| Cash and Cash Equivalents, Beginning of the Period |
49,050
|
143,876
|
- | - |
| Cash and Cash Equivalents, End of the Period |
426,575
|
49,049
|
- | - |
| All Figures in | Thousands | Thousands | ||
| All Currency In | ^ | ^ | ||
| Last Update Date | 2025-03-05 | 2024-03-25 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total Assets |
5,914,940
|
5,551,661
|
5,643,971
|
5,366,838
|
| Total Liabilities |
2,014,360
|
1,863,071
|
1,725,836
|
1,828,970
|
| Total Shareholders Equity (After Deducting the Minority Equity) |
3,752,009
|
3,552,351
|
3,765,386
|
3,400,977
|
| Total Liabilities and Shareholders Equity |
5,914,940
|
5,551,661
|
5,643,971
|
5,366,838
|
| Statement of Income | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Total Revenue (Sales/Operating) |
777,325
|
796,355
|
764,347
|
710,744
|
| Net Profit (Loss) before Zakat and Tax |
204,615
|
195,895
|
206,756
|
158,697
|
| Zakat and Income Tax |
-4,957
|
-8,929
|
-9,708
|
-9,052
|
| Net Profit (Loss) Attributable to Shareholders of the Issuer |
199,657
|
186,965
|
197,048
|
149,645
|
| Total Comprehensive Income Attributable to Shareholders of the Issuer |
199,657
|
186,965
|
197,048
|
149,645
|
| Profit (Loss) per Share |
1
|
1.92
|
0.99
|
0.75
|
| Cash Flows | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Net Cash From Operating Activities |
814,641
|
338,930
|
264,516
|
811,477
|
| Net Cash From Investing Activities |
-633,103
|
-200,239
|
-135,773
|
-400,344
|
| Net Cash From Financing Activities |
-141,083
|
-239,109
|
33,065
|
-369,223
|
| Cash and Cash Equivalents, Beginning of the Period |
426,575
|
426,575
|
426,575
|
49,050
|
| Cash and Cash Equivalents, End of the Period |
467,030
|
326,156
|
588,383
|
90,960
|
| All Figures in | Thousands | Thousands | Thousands | Thousands |
| All Currency In | ^ | ^ | ^ | ^ |
| Last Update Date | 2025-10-30 | 2025-07-29 | 2025-05-05 | 2024-11-05 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Peer Comparison
Note:Display data relevant only to the corresponding class of shares only
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The Companys main activities are operating hospitals and dispensaries, which are either owned, rented or for a percentage of revenues as per the signed contracts
Company History
The origin of Mouwasat dates back to 1974 when an establishment solely owned by Mr. Mohammad Sultan Al-Subaie was established with a share capital of 100,000 SAR for the management and operation of medical facilities and started with the launching of Mouwasat Dispensary in Dammam in 1975. The Company established its first owned comprehensive medical facility in 1984 known as Mouwasat Hospital in Dammam, which commenced operation in 1988
Company Bylaws
Equity Profile
- Authorized Capital (^) 2,000,000,000
- Total Issued Shares 200,000,000
- Paid Capital (^) 2,000,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2023-08-08
Investment limits
There are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Mostafa Hosni Mostafa
Company Address:
Destect 71 - King Fahad Road P.O.Box 282 Dammam31411
Contact Details:
Telephone:
0138200016
Fax
: -
Email
: shares@mouwasat.com
Company Website:
| Name Of Subsidiary | Percentage Of Property | Main Business | Location Of Operation | Country Of Operation |
|---|---|---|---|---|
| Eastern Medical Services Co | 51.00% | Establishment, operation and administration of hospitals, clinics and private medical clinics | Kingdom of Saudi Arabia - Qatif | Kingdom of Saudi Arabia |
| Jeddah Doctors Co. | 51.00% | Medical Operation of Hospitals | Kingdom of Saudi Arabia - Jeddah | Kingdom of Saudi Arabia |
| Modawa and Rieaya Medical Co | 51.00% | Consultancy Medical Clinics | Kingdom of Saudi Arabia - Khobar | Kingdom of Saudi Arabia |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}